Avery. Neonatología Sample

Edited with the trial version of Foxit Advanced PDF Editor To remove this notice, visit: www.foxitsoftware.com/shopping

132

PARTE 2 •  El feto como paciente

102. Manning FA, Harrison MR, Rodeck C. Catheter shunts for fetal hydro- nephrosis and hydrocephalus. Report of the international fetal surgery registry. N Engl J Med 1986;315:336. 103. Manning M, Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12(11):742. 104. Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2012;32(10):976. 105. Handyside AH, Robinson MD, Simpson RJ, et al. Isothermal whole genome amplification from single and small numbers of cells: a new era for preimplantation genetic diagnosis of inherited disease. Mol Hum Reprod 2004;10(10):767. 106. Eggerding FA. A one-step coupled amplification and oligonucleotide ligation procedure for multiplex genetic typing. PCR Methods Appl 1995;4:337. 107. Le Caignec C, Spits C, Sermon K, et al. Single-cell chromosomal imbal- ances detection by array CGH. Nucleic Acids Res 2006;34:e68. 108. Verlinsky Y, Cieslak J, Freidine M, et al. Pregnancies following pre- conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Hum Reprod 1995;10:1923. 109. Wilton L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat Diagn 2002;22:512. 110. Mastenbroek S, Twisk M, van der Veen F, et al. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011;17(4):454. 111. Liebaers I, Desmyttere S, Verpoest W, et al. Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum Reprod 2010;25(1):275. 112. Pryde PG, Odgers AE, Isada NB, et al. Determinants of parental decision to abort (DTA) or continue for non-aneuploid ultrasound detected abnor- malities. Obstet Gynecol 1992;80:52. 113. Abortion Resources. Guttmacher Institute. http://www.guttmacher.org/ sections/abortion.php, January 2014. 114. Raymond ED, Grimes DA. The comparative safety of legal induced abor- tion and childbirth in the United States. Obstet Gynecol 2012;119:215. 115. Creinin MD, Danielson KG. Medical abortion in early pregnancy. In: Paul M, Lichtenberg S, Borgatta L, et al., eds. Management of unintended and abnormal pregnancy . Oxford: Wiley Blackwell, 2009:111. 116. Evans MI, Chrousos GP, Mann DL, et al. Pharmacologic suppression of the fetal adrenal gland in utero: attempted prevention of abnormal exter- nal genital masculinization in suspected congenital adrenal hyperplasia. JAMA 1985;253:1015. 117. Chasen ST, Kalish RB, Gupta M, et al. Dilatation and evacuation at >or =20 weeks: comparison of operative techniques. Am J Obstet Gynecol 2004;190:1180. 118. Hern WM. Fetal diagnostic indications for second and third trimester out- patient pregnancy termination. Prenat Diagn 2014;34:438. 119. Phil Kline is indefinitely suspended from practicing law. Kansas City Star. Oct 18, 2013 . http://www.kansascity.com/2013/10/18/4560734/ kline-indefinitely-suspended-from.html 120. Evans MI, Dommergues M, Wapner RJ, et al. Efficacy of transabdomi- nal multifetal pregnancy reduction: collaborative experience among the world’s largest centers. Obstet Gynecol 1993;82:61. 121. Evans MI, Andriole SA, Britt DW. Fetal reduction – 25 years’ experience. Fetal Diagn Ther 2014;35:69. 122. Evans MI, Kaufman M, Urban AJ, et al. Fetal reduction from twins to a singleton: a reasonable consideration. Obstet Gynecol 2004:104:232. 123. Evans MI, Rosner M, Andriole S, et al. Evolution of gender preferences in multiple pregnancies. Prenat Diagn 2013;33:935. 124. Evans MI, Andriole S, Pergament E, et al. Paternity balancing. Fetal Diagn Ther 2013;34:135. 125. Evans MI, Goldberg J, Horenstein J, et al. Selective termination (ST) for structural (STR), chromosomal (CHR), and Mendelian (MEN) anomalies: International experience. Am J Obstet Gynecol 1999;181(4):893. 126. Hack KE, Derks JB, Elias SG, et al. Increased perinatal mortality and morbidity in monochorionic versus dichorionic twin pregnancies: clini- cal implications of a large Dutch cohort study. BJOG 2008;115:58. 127. Evans MI, Sacks AL, Johnson MP, et al. Sequential invasive assessment of fetal renal function, and the in utero treatment of fetal obstructive uropathies. Obstet Gynecol 1991:77:545. 128. Wu S, Johnson MP. Fetal lower urinary tract obstruction. Clin Perinatol 2009;36:377. 129. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery ver- sus serial amnioreduction for severe twin to twin transfusion syndrome. N Engl J Med 2004;351:136. 130. Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfu- sion syndrome. J Perinatol 1999;19:550. 131. Harrison MR, Longaker MT, Adzick NS, et al. Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med 1990;322:1582.

72. Evans MI, Rozner G, Yaron Y, et al. CVS. In: Evans MI, Johnson MP, Yaron Y, Drugan A, eds. Prenatal diagnosis: genetics, reproductive risks, test- ing, and management . New York: McGraw Hill Publishing Co., 2006:433. 73. Rudnicki M, Vejerslev LO, Junge J. The vanishing twin: morphologic and cytogenetic evaluation of an ultrasonographic phenomenon. Gynecol Obstet Invest 1991;31:141. 74. Johnson MP, Drugan A, Koppitch FC, et al. Postmortem CVS is a better method for cytogenetic evaluation of early fetal loss than culture of abor- tus material. Am J Obstet Gynecol 1990;163:1505. 75. Drugan A, Johnson MP, Isada NB, et al. The smaller than expected first tri- mester fetus is at increased risk for chromosome anomalies. Am J Obstet Gynecol 1992;167:1525. 76. Silverman NS, Sullivan MW, Jungkind DL, et al. Incidence of bac- teremia associated with chorionic villus sampling. Obstet Gynecol 1994;84(6):1021. 77. Ledbetter DH, Martin AO, Verlinsky Y, et al. Cytogenetic results of cho- rionic villus sampling: high success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol 1990;162:495. 78. Brun JL, Mangione R, Gangbo F, et al. Feasibility, accuracy and safety of chorionic villus sampling: a report of 10741 cases. Prenat Diagn 2003;23(4):295. 79. Ledbetter DH, Zachary JL, Simpson MS, et al. Cytogenetic results from the US collaborative study on CVS. Prenat Diagn 1992;12(5):317. 80. Kotzot D. Abnormal phenotypes in uniparental disomy (UPD): fundamen- tal aspects and a critical review with bibliography of UPD other than 15. Am J Med Genet 1999;83(2):265. 81. Evans MI, Greb A, Kazazian Jr HH, et al. In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy. Am J Obstet Gynecol 1991;165:728. 82. Evans MI, Krivchenia EL, Johnson MP, et al. In utero fetal muscle biopsy alters diagnosis and carrier risks in Duchenne and Becker muscular dys- trophy. Fetal Diagn Ther 1995;10(2):71. 83. Holzgreve W, Golbus MS. Prenatal diagnosis of ornithine transcarbamy- lase deficiency utilizing fetal liver biopsy. Am J Hum Genet 1984;36:320. 84. Evans MI, Holzgreve W, Krivchenia EL, et al. Tissue biopsies. In: Evans MI, Johnson MP, Yaron Y, Drugan A, eds. Prenatal diagnosis: genetics, reproductive risks, testing, and management . New York: McGraw Hill Publishing Co., 2006:449. 85. Hsu LYF, Kaffe S, Perlis TE. Trisomy 20 mosaicism in prenatal diagnosis— a review and update. Prenat Diagn 1987;7(8):581. 86. Freda VJ, Adamson KJ. Exchange transfusion in utero. Am J Obstet Gynecol 1964;89:817. 87. Daffos F, Cappella-Pavlovsky M, Forestier F. Fetal blood sampling via the umbilical cord using a needle guided by ultrasound: report of 66 cases. Prenat Diagn 1983;3:271. 88. Nicolaides KH, Soothill PW, Rodeck CH, et al. Ultrasound guided sampling of umbilical cord and placental blood to access fetal well being. Lancet 1986;1:1065. 89. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: state of the art 2006. Am J Obstet Gynecol 2006;195:907. 90. Harman CR, Bowman JM, Manning FA, et al. Intrauterine transfusion: intraperitoneal versus intravascular approach: a case control compari- son. Am J Obstet Gynecol 1990;162:1053. 91. Moldenhauer JS. Ex utero intrapartum therapy. Semin Pediatr Surg 2013;22:44. 92. van Ommen GJ, Breuning MH, Raap AK. FISH in genome research and molecular diagnostics. Curr Opin Genet Dev 1995;5(3):304. 93. Trask BJ. Fluorescence in situ hybridization: applications in cytogenetics and gene mapping. Trends Genet 1991;7(5):149. 94. Pinkel D, Straume T, Grey JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 1986;83:2934. 95. Sullivan BA, Leana-Cox J, Schwartz S. Clarification of subtle reciprocal rearrangements using fluorescent in situ hybridization. Am J Med Genet 1993;47:223. 96. Evans MI, Klinger KW, Isada NB, et al. Rapid prenatal diagnosis by fluo- rescent in situ hybridization of chorionic villi: an adjunct to long-term culture and karyotype. Am J Obstet Gynecol 1992;167:1522. 97. Verlinsky Y, Cieslak J, Freidine M, et al. Polar body diagnosis of common aneuploidies by FISH. J Assist Reprod Genet 1996;13:157. 98. Evans MI, Lau TK. Making decisions when no good options exist: delivery of the survivor after intrauterine death of the co-twin in monochorionic twin pregnancies. Fetal Diagn Ther 2010;28:191. 99. Quintero RA, Reich H, Puder KS, et al. Brief report: umbilical cord liga- tion of an acardiac twin by fetoscopy at 19 weeks of gestation. N Engl J Med 1994;330:469. 100. Gebb J, Rosner M, Dar P, et al. Long term neurologic outcomes after fetal interventions: meta analysis. Am J Obstet Gynecol 2014;210:S115. 101. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;2:1107.

AMPLE